Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

被引：80

作者：

Haidar, Ghady ^{[1
]}

Agha, Mounzer ^{[2
]}

Bilderback, Andrew ^{[3
]}

Lukanski, Amy ^{[3
]}

Linstrum, Kelsey ^{[4
]}

Troyan, Rachel ^{[3
]}

Rothenberger, Scott ^{[5
]}

McMahon, Deborah K. ^{[1
]}

Crandall, Melissa D. ^{[6
]}

Sobolewksi, Michele D. ^{[1
]}

Enick, P. Nathan ^{[1
]}

Jacobs, Jana L. ^{[1
]}

Collins, Kevin ^{[7
]}

Klamar-Blain, Cynthia ^{[1
]}

Macatangay, Bernard J. C. ^{[1
]}

Parikh, Urvi M. ^{[1
]}

Heaps, Amy ^{[1
]}

Coughenour, Lindsay ^{[1
]}

Schwartz, Marc B. ^{[8
]}

Dueker, Jeffrey M. ^{[8
]}

Silveira, Fernanda P. ^{[1
]}

Keebler, Mary E. ^{[9
]}

Humar, Abhinav ^{[10
]}

Luketich, James D. ^{[11
]}

Morrell, Matthew R. ^{[12
]}

Pilewski, Joseph M. ^{[13
]}

McDyer, John F. ^{[13
]}

Pappu, Bhanu ^{[2
]}

Ferris, Robert L. ^{[2
]}

Marks, Stanley M. ^{[2
]}

Mahon, John ^{[6
]}

Mulvey, Katie ^{[6
]}

Hariharan, Sundaram ^{[10
,14
]}

Updike, Glenn M. ^{[15
,16
]}

Brock, Lorraine ^{[3
]}

Edwards, Robert ^{[15
,16
]}

Beigi, Richard H. ^{[15
,16
]}

Kip, Paula L. ^{[3
]}

Wells, Alan ^{[6
,17
]}

Minnier, Tami ^{[3
]}

Angus, Derek C. ^{[4
]}

Mellors, John W. ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15213 USA

[2] Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15213 USA

[3] Univ Pittsburgh, Wolff Ctr, Med Ctr, Pittsburgh, PA 15213 USA

[4] Univ Pittsburgh, Med Ctr, Hlth Care Innovat, Pittsburgh, PA 15213 USA

[5] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA

[6] Univ Pittsburgh, Med Ctr, Clin Lab, Pittsburgh, PA 15213 USA

[7] Univ Pittsburgh, Med Ctr, Clin Analyt, Pittsburgh, PA 15213 USA

[8] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA

[9] Univ Pittsburgh, Sch Med, Dept Cardiol, Pittsburgh, PA 15213 USA

[10] Univ Pittsburgh, Sch Med, Dept Surg, Div Transplantat, Pittsburgh, PA 15213 USA

[11] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA

[12] Univ Utah, Sch Med, Div Pulm & Crit Care, Salt Lake City, UT USA

[13] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA

[14] Univ Pittsburgh, Med Ctr, Transplant Nephrol, Pittsburgh, PA 15213 USA

[15] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA

[16] UPMC Magee Womens Hosp, Pittsburgh, PA USA

[17] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 01期

基金：

美国国家卫生研究院;

关键词：

COVID-19; vaccines; SARS-COV-2; antibody; immunocompromised; SARS-CoV-2; neutralization;

D O I：

10.1093/cid/ciac103

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background We studied humoral responses after coronavirus disease 2019 (COVID-19) vaccination across varying causes of immunodeficiency. Methods Prospective study of fully vaccinated immunocompromised adults (solid organ transplant [SOT], hematologic malignancy, solid cancers, autoimmune conditions, human immunodeficiency virus [HIV]) versus nonimmunocompromised healthcare workers (HCWs). The primary outcome was the proportion with a reactive test (seropositive) for immunoglobulin G to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain. Secondary outcomes were comparisons of antibody levels and their correlation with pseudovirus neutralization titers. Stepwise logistic regression was used to identify factors associated with seropositivity. Results A total of 1271 participants enrolled: 1099 immunocompromised and 172 HCW. Compared with HCW (92.4% seropositive), seropositivity was lower among participants with SOT (30.7%), hematological malignancies (50.0%), autoimmune conditions (79.1%), solid tumors (78.7%), and HIV (79.8%) (P < .01). Factors associated with poor seropositivity included age, greater immunosuppression, time since vaccination, anti-CD20 monoclonal antibodies, and vaccination with BNT162b2 (Pfizer) or adenovirus vector vaccines versus messenger RNA (mRNA)-1273 (Moderna). mRNA-1273 was associated with higher antibody levels than BNT162b2 or adenovirus vector vaccines after adjusting for time since vaccination, age, and underlying condition. Antibody levels were strongly correlated with pseudovirus neutralization titers (Spearman r = 0.89, P < .0001), but in seropositive participants with intermediate antibody levels, neutralization titers were significantly lower in immunocompromised individuals versus HCW. Conclusions Antibody responses to COVID-19 vaccines were lowest among SOT and anti-CD20 monoclonal recipients, and recipients of vaccines other than mRNA-1273. Among those with intermediate antibody levels, pseudovirus neutralization titers were lower in immunocompromised patients than HCWs. Additional SARS-CoV-2 preventive approaches are needed for immunocompromised persons, which may need to be tailored to the cause of immunodeficiency. In this prospective study of 1271 participants, seropositivity after COVID-19 vaccination varied by condition: HCW (92.4%), HIV (79.8%), autoimmune conditions (79.1%), solid tumors (78.7%), hematological malignancies (50.0%), and SOT (30.7%). Additional strategies are needed to protect immunocompromised patients from COVID-19.

引用

页码：E630 / E644

页数：15

共 36 条

[31] Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients [J].

Vijenthira, Abi ;

Gong, Inna ;

Betschel, Stephen D. ;

Cheung, Matthew ;

Hicks, Lisa K. .

BLOOD ADVANCES, 2021, 5 (12) :2624-2643

[32] Immunogenicity of Influenza Vaccination in Patients With Cancer [J].

Waqar, Saiama N. ;

Boehmer, Leigh ;

Morgensztern, Daniel ;

Wang-Gillam, Andrea ;

Sorscher, Steven ;

Lawrence, Steven ;

Gao, Feng ;

Guebert, Kalin ;

Williams, Kristina ;

Govindan, Ramaswamy .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03) :248-253

[33] Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series [J].

Werbel, William A. ;

Boyarsky, Brian J. ;

Ou, Michael T. ;

Massie, Allan B. ;

Tobian, Aaron A. R. ;

Garonzik-Wang, Jacqueline M. ;

Segev, Dorry L. .

ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) :1330-+

[34]

www.cdc.gov, INTERIM CLIN CONSIDE

[35]

Zilla M, 2021, AM J CLIN PATHOL, V155, P343, DOI [10.1093/ajcp/aqaa228, 10.1093/AJCP/AQAA228]

[36] SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients [J].

Zilla, Megan L. ;

Keetch, Christian ;

Mitchell, Gretchen ;

McBreen, Jeffery ;

Shurin, Michael R. ;

Wheeler, Sarah E. .

JOURNAL OF APPLIED LABORATORY MEDICINE, 2021, 6 (02) :486-490

← 1 2 3 4 →